SPONSOR
Acerand Therapeutics (Shanghai) Limited
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Solid Tumor, AdultBRCA1 MutationBRCA2 MutationOvarian CancerBreast CancerProstate Cancer
Acerand Therapeutics (Shanghai) Limited is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Acerand Therapeutics (Shanghai) Limited
How many clinical trials has Acerand Therapeutics (Shanghai) Limited sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Acerand Therapeutics (Shanghai) Limited, of which 1 are actively recruiting participants. These trials cover conditions including Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Acerand Therapeutics (Shanghai) Limited research focus on?
Acerand Therapeutics (Shanghai) Limited clinical trials span Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer, Breast Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Acerand Therapeutics (Shanghai) Limited clinical trial?
To participate in a Acerand Therapeutics (Shanghai) Limited trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Acerand Therapeutics (Shanghai) Limited trials with current recruitment status updated daily.
Clinical Trials by Acerand Therapeutics (Shanghai) Limited
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology